Vesicular stomatitis virus modified with single chain IL-23 exhibits oncolytic activity against tumor cells in vitro and in vivo

Article English OPEN
Reiss, Carol Shoshkes (2010)
  • Publisher: Dove Press
  • Journal: International Journal of Interferon, Cytokine and Mediator Research (issn: 1179-139X)
  • Related identifiers: doi: 10.2147/IJICMR.S9528
  • Subject: International Journal of Interferon, Cytokine and Mediator Research

James M Miller1, Sarah McNulty Bidula1,5, Troels Mygind Jensen1,6, Carol Shoshkes Reiss1,2,3,41Department of Biology, New York University, New York, NY, USA; 2Center for Neural Science, NYU; 3NYU Cancer Institute; 4Departments of Microbiology, NYU School of Medicine and... View more
  • References (49)
    49 references, page 1 of 5

    1. Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin. 2005;55:10-30.

    2. Tseng JC, Levin B, Hurtado A, et al. Systemic tumor targeting and killing by Sindbis viral vectors. Nat Biotechnol. 2004;22:70-77.

    3. Vigil A, Park MS, Martinez O, et al. Use of reverse genetics to enhance the oncolytic properties of newcastle disease virus. Cancer Res. 2007;67:8285-8292.

    4. Hu JCC, Coffin RS, Davis CJ, et al. A phase I study of OncoVEX(GMCSF), a second-generation oncolytic herpes simplex virus expressing granulocyte macrophage colony-stimulating factor. Clin Cancer Res. 2006;12:6737-6747.

    5. Barber GN. Vesicular stomatitis virus as an oncolytic vector. Viral Immunol. 2004;17:516-527.

    6. Stojdl DF, Lichty B, Knowles S, et al. Exploiting tumor-specicfi defects in the interferon pathway with a previously unknown oncolytic virus. Nat Med. 2000;6:821-825.

    7. Ebert O, Harbaran S, Shinozaki K, Woo SL. Systemic therapy of experimental breast cancer metastases by mutant vesicular stomatitis virus in immune-competent mice. Cancer Gene Ther. 2005;12:350-358.

    8. Huang TG, Ebert O, Shinozaki K, Garcia-Sastre A, Woo SLC. Oncolysis of hepatic metastasis of colorectal cancer by recombinant vesicular stomatitis virus in immune-competent mice. Mol Ther. 2003;8:434-440.

    9. Shi W, Tang QQ, Chen XC, et al. Antitumor and antimetastatic activities of vesicular stomatitis virus matrix protein in a murine model of breast cancer. J Mol Med. 2009;87:493-506.

    10. Gao Y, Whitaker-Dowling P, Griffin JA, Barmada MA, Bergman I. Recombinant vesicular stomatitis virus targeted to Her2/neu combined with anti-CTLA4 antibody eliminates implanted mammary tumors. Cancer Gene Ther. 2009;16:44-52.

  • Similar Research Results (2)
  • Metrics
    No metrics available
Share - Bookmark